Search icon

AIM IMMUNOTECH INC. - Florida Company Profile

Company claim

Is this your business?

Get access!

Company Details

Entity Name: AIM IMMUNOTECH INC.
Jurisdiction: FLORIDA
Filing Type: Foreign Profit
Status: Active

The business entity is active. This status indicates that the business is currently operating and compliant with state regulations, suggesting a lower risk profile for lenders and potentially better creditworthiness.

Date Filed: 15 Dec 2004 (21 years ago)
Last Event: NAME CHANGE AMENDMENT
Event Date Filed: 17 Sep 2019 (6 years ago)
Document Number: F04000007248
FEI/EIN Number 520845822

Federal Employer Identification (FEI) Number assigned by the IRS.

Address: 2117 SW Highway 484, OCALA, FL, 34473, US
Mail Address: 2117 SW Highway 484, Ocala, FL, 34473, US
ZIP code: 34473
County: Marion
Place of Formation: DELAWARE

Key Officers & Management

Name Role Address
EQUELS THOMAS K Chief Executive Officer 2117 SW HIGHWAY 484, OCALA, FL, 34473
MITCHELL WILLIAM MM.D. Director 2117 SW Highway 484, Ocala, FL, 34473
Rodino Peter WIII, J. Secretary 2117 SW Highway 484, Ocala, FL, 34473
EQUELS THOMAS KEsq. Agent 2117 SW Highway 484, Ocala, FL, 34473
Dickey Robert Chief Financial Officer 2117 SW Highway 484, OCALA, FL, 34473
Bryan Nancy Director 7816 Broadmoor Pines Blvd, Sarasota, FL, 34243
Kellner Ted K Director 2117 SW Highway 484, OCALA, FL, 34473

U.S. Small Business Administration Profile

The U.S. Small Business Administration (SBA) helps Americans start, grow, and build resilient businesses.

Note: SBA was created in 1953 as an independent agency of the federal government to aid, counsel, assist and protect the interests of small business concerns; preserve free competitive enterprise; and maintain and strengthen the overall economy of our nation. SBA reviews Congressional and testifies on behalf of small businesses. It assesses the impact of regulatory burden on small businesses.

Phone Number:
Contact Person:
ANN MARIE COVERLY
Ownership and Self-Certifications:
Self-Certified Small Disadvantaged Business
User ID:
P2975213

Form 5500 Series

Employer Identification Number (EIN):
520845822
Plan Year:
2023
Number Of Participants:
42
Sponsors Telephone Number:
Plan Year:
2022
Number Of Participants:
40
Sponsors Telephone Number:
Plan Year:
2021
Number Of Participants:
38
Sponsors Telephone Number:
Plan Year:
2020
Number Of Participants:
40
Sponsors Telephone Number:
Plan Year:
2019
Number Of Participants:
42
Sponsors Telephone Number:

Events

Event Type Filed Date Value Description
NAME CHANGE AMENDMENT 2019-09-17 AIM IMMUNO TECH INC. -
REGISTERED AGENT ADDRESS CHANGED 2019-04-18 2117 SW Highway 484, Ocala, FL 34473 -
CHANGE OF PRINCIPAL ADDRESS 2019-04-17 2117 SW Highway 484, OCALA, FL 34473 -
CHANGE OF MAILING ADDRESS 2019-03-18 2117 SW Highway 484, OCALA, FL 34473 -
REINSTATEMENT 2017-01-05 - -
REVOKED FOR ANNUAL REPORT 2016-09-23 - -
REGISTERED AGENT NAME CHANGED 2015-04-22 EQUELS, THOMAS K, Esq. -
REINSTATEMENT 2009-03-19 - -
REVOKED FOR ANNUAL REPORT 2005-09-16 - -

Documents

Name Date
ANNUAL REPORT 2024-02-05
ANNUAL REPORT 2023-01-25
AMENDED ANNUAL REPORT 2022-04-13
ANNUAL REPORT 2022-02-07
ANNUAL REPORT 2021-02-04
ANNUAL REPORT 2020-01-13
Name Change 2019-09-17
AMENDED ANNUAL REPORT 2019-04-18
ANNUAL REPORT 2019-03-18
ANNUAL REPORT 2018-04-16

USAspending Awards / Financial Assistance

Date:
2020-04-13
Awarding Agency Name:
Small Business Administration
Transaction Description:
TO AID SMALL BUSINESSES IN MAINTAINING WORK FORCE DURING COVID-19 PANDEMIC.
Obligated Amount:
0.00
Face Value Of Loan:
588000.00
Total Face Value Of Loan:
0.00

Trademarks

Serial Number:
90525193
Mark:
ALFERON N INJECTION
Status:
A fifth request for extension of time to file a Statement of Use has been granted.
Mark Type:
Trademark
Application Filing Date:
2021-02-11
Mark Drawing Type:
4 - STANDARD CHARACTER MARK
Mark Literal Elements:
ALFERON N INJECTION

Goods And Services

For:
Interferons; parenterally administered interferons for use in treating viral diseases and immunological disorders
International Classes:
005 - Primary Class
Class Status:
ACTIVE
Serial Number:
88788692
Mark:
AIM
Status:
Suspension check completed. Application remains suspended.
Mark Type:
Trademark, Service Mark
Application Filing Date:
2020-02-07
Mark Drawing Type:
4 - STANDARD CHARACTER MARK
Mark Literal Elements:
AIM

Goods And Services

For:
Intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of injuries resulting from surgery, thermal ac...
International Classes:
005 - Primary Class
Class Status:
ACTIVE
For:
Pharmaceutical research and development; Pharmaceutical research and development of drugs for the treatment of cancers, viral diseases, immunological disorders and ME/CFS
International Classes:
042 - Primary Class
Class Status:
ACTIVE
Serial Number:
88604388
Mark:
AIM IMMUNOTECH
Status:
Registered. The registration date is used to determine when post-registration maintenance documents are due.
Mark Type:
Trademark, Service Mark
Application Filing Date:
2019-09-04
Mark Drawing Type:
3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S) /NUMBER(S)
Mark Literal Elements:
AIM IMMUNOTECH

Goods And Services

For:
Intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of injuries resulting from surgery, thermal ac...
First Use:
2023-06-07
International Classes:
005 - Primary Class
Class Status:
ACTIVE
For:
Pharmaceutical research and development; Pharmaceutical research and development of drugs for the treatment of cancers, viral diseases, immunological disorders and ME/CFS
First Use:
2019-09-20
International Classes:
042 - Primary Class
Class Status:
ACTIVE
Serial Number:
88588339
Mark:
AIM BIOTECH
Status:
Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Mark Type:
Trademark, Service Mark
Application Filing Date:
2019-08-22
Mark Drawing Type:
4 - STANDARD CHARACTER MARK
Mark Literal Elements:
AIM BIOTECH

Goods And Services

For:
Intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of injuries resulting from surgery, thermal ac...
International Classes:
005 - Primary Class
Class Status:
ACTIVE
For:
Pharmaceutical research and development; Pharmaceutical research and development of drugs for the treatment of cancers, viral diseases, immunological disorders and ME/CFS
International Classes:
042 - Primary Class
Class Status:
ACTIVE
Serial Number:
88588324
Mark:
AIM IMMUNOTECH
Status:
Registered. The registration date is used to determine when post-registration maintenance documents are due.
Mark Type:
Trademark, Service Mark
Application Filing Date:
2019-08-22
Mark Drawing Type:
4 - STANDARD CHARACTER MARK
Mark Literal Elements:
AIM IMMUNOTECH

Goods And Services

For:
Intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of injuries resulting from surgery, thermal ac...
First Use:
2023-06-07
International Classes:
005 - Primary Class
Class Status:
ACTIVE
For:
Pharmaceutical research and development; Pharmaceutical research and development of drugs for the treatment of cancers, viral diseases, immunological disorders and ME/CFS
First Use:
2019-09-20
International Classes:
042 - Primary Class
Class Status:
ACTIVE

Reviews Leave a review

This company hasn't received any reviews.

Date of last update: 03 Jun 2025

Sources: Florida Department of State